Savaria (FRA:S97) 3-1 Month Momentum %: 3.37% (As of Aug. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:S97 Savaria Corp FRA:S97
94 GF Score
Price €17.70
GF Value €13.13
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Savaria 3-1 Month Momentum %?

Savaria FRA:S97 +2.31% 94 3-1 Month Momentum % is 3.37% as of Aug. 27, 2026. GuruFocus rates FRA:S97 with a GF Score™ of 94/100 and a GF Value™ of €13.13 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 3,066 Industrial Products companies, Savaria ranks better than 84.02% on this metric.

3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-27), Savaria's 3-1 Month Momentum % is 3.37%.

The industry rank for Savaria's 3-1 Month Momentum % or its related term are showing as below:

FRA:S97's 3-1 Month Momentum % is ranked better than
84.02% of 3066 companies
in the Industrial Products industry
Industry Median: -11.975 vs FRA:S97: 3.37

Savaria  (FRA:S97) 3-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Savaria 3-1 Month Momentum % Related Terms


FRA:S97 vs GEV, ETN, PH: 3-1 Month Momentum % Comparison

For the Specialty Industrial Machinery subindustry, Savaria's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Savaria 3-1 Month Momentum % vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, Savaria's 3-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Savaria's 3-1 Month Momentum % falls into.


FRA:S97
94GF Score
Savaria Corp FRA:S97
3-1 Month Momentum % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Savaria  (FRA:S97) 3-1 Month Momentum % Calculation

3-1 Month Momentum % is calculated as following:

3-1 Month Momentum %=( Price 1-month ago / Price 3-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 3-1 Month Momentum % →
What does a 3-1 Month Momentum % of 3.37% mean?
Savaria (FRA:S97) has a 3-1 Month Momentum % of 3.37% as of Aug. 27, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Savaria and its competitors. According to the industry distribution chart, Savaria ranks #490 out of 3066 companies in the Industrial Products industry, placing it in the top 16%.
Is Savaria's 3-1 Month Momentum % too high?
Savaria's current 3-1 Month Momentum % is 3.37%. Based on the distribution chart, Savaria ranks #490 out of 3066 companies in the Industrial Products industry, which is in the top quartile — a strong position relative to peers. Overall, Savaria has a GF Score™ of 94/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Savaria's 3-1 Month Momentum % compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Savaria ranks #490 out of 3066 companies for 3-1 Month Momentum %. This places Savaria in the top 16% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for an Industrial Products company?
A good 3-1 Month Momentum % depends on the Industrial Products industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Savaria and its competitors. Savaria's current 3-1 Month Momentum % is 3.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Savaria stock overvalued right now?
Based on GuruFocus' analysis, Savaria (FRA:S97) is currently considered Significantly Overvalued. The stock's GF Value™ is €13.13, compared to a current price of €17.70 — trading 34.8% above its estimated fair value. The current 3-1 Month Momentum % is 3.37%. Savaria's overall GF Score™ is 94/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Savaria (FRA:S97), the current 3-1 Month Momentum % is 3.37% as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Savaria (FRA:S97) Overvalued in 2026?

Based on GuruFocus' analysis, Savaria stock appears to be overvalued. The current stock price of €17.70 is trading 34.8% above its estimated GF Value™ of €13.13. GuruFocus considers Savaria to be Significantly Overvalued.

Key valuation signals for FRA:S97:

  • 3-1 Month Momentum %: 3.37%
  • GF Value™: €13.13 vs. price of €17.70 (34.8% above fair value)
  • GF Score™: 94/100 with 6 warning signs

No single metric tells the full story. See the FRA:S97 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Savaria Business Description

Other Exchanges SISXF:USASIS:Canada
Address 4350 Autoroute Chomedey, Laval, QC, CAN, H7R 6E9
Savaria Corp designs, engineers, and manufactures products for personal mobility. Its products include home elevators, wheelchair lifts, commercial elevators, ceiling lifts, stairlifts, and van conversions. The company's operating segments are Accessibility and Patient Care. The Accessibility segment deals with manufacturing, designing, installing, and distributing elevators, platform lifts, and stairlifts for people with mobility challenges. The Patient Care segment includes the manufacturing and distribution of a comprehensive line of therapeutic support surfaces and other pressure management products for the medical market. The company derives maximum revenue from Accessibility segment.
94GF Score

Get the complete analysis for FRA:S97

3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.70
Price
€13.13
GF Value